New research appearing in the Journal of the National Comprehensive Cancer Network found that incorporating information from ...

Almost three-fourths of patients with biochemically recurrent prostate cancer remained metastasis free at 5 years following ...

New research in the February 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans ...

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...

Breakthrough for prostate cancer patients as NHS now offers life-extending drug - The new medication is suitable for patients who are unable to receive chemotherapy or standard treatments ...

A new combination of drugs could help delay the advancement of a deadly form of prostate cancer in those with an advanced form of the disease, new research has found. The “striking” findings showed an ...

In a statement, NICE said the new guidance for Talzenna will make it an option for around 2,400 people in England and reduce pressure on the NHS, as current therapies can require clinic visits. The ...

Radiation therapy (also called radiotherapy) uses high-energy beams or subatomic particles to damage the DNA inside prostate cancer cells. After enough damage, the cells cannot multiply, and they die.

If your cancer is not causing any symptoms, is growing slowly, or is small and only in your prostate, your physician may suggest active surveillance or watchful waiting instead of treatment. Active ...